Jungnik A, Arrubla Martinez J, Plum-Mrschel L, Kapitza C, Lamers D, Thamer C, et al
Patients who experience early nausea sometimes find that evening dosingtimed 23 hours after their last mealallows the medication to settle without competing with hunger signals during eating times
Gastrointestinal conditions can affect both drug absorption and tolerability
Many patients and their prescribers choose maintenance-phase dosing rather than abrupt cessation
Why nutrition and strength training matter more than the number on the scales GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have changed the landscape of weight-loss treatment
, , , .253,254 GLP-1 GLP-1(7-36) , 36 .255 GLP-1(7-36) - - GLP-1R .241 DPP-4 GLP-1(7-36) 8 GLP-1(936)